Adding low‐dose gemtuzumab ozogamicin to fludarabine, Ara‐C and idarubicin (MY‐FLAI) may improve disease‐free and overall survival in elderly patients with non …
M Clavio, L Vignolo, A Albarello… - British journal of …, 2007 - Wiley Online Library
We report the final results of a prospective multi‐centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low …
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low …
[引用][C] Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with …
M CLAVIO - Br J Haematol., 2007 - cir.nii.ac.jp
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may
improve disease-free and overall survival in elderly patients with non-M3 acute myeloid …
improve disease-free and overall survival in elderly patients with non-M3 acute myeloid …
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non …
M Clavio, L Vignolo, A Albarello… - British Journal of …, 2007 - search.ebscohost.com
We report the final results of a prospective multi-centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …
[引用][C] Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with …
M CLAVIO, L VIGNOLO, E BALLEARI… - British journal of …, 2007 - pascal-francis.inist.fr
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI)
may improve disease-free and overall survival in elderly patients with non-M3 acute …
may improve disease-free and overall survival in elderly patients with non-M3 acute …
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non …
M Clavio, L Vignolo, A Albarello… - British journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
We report the final results of a prospective multi-centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non …
M Clavio, L Vignolo, A Albarello, R Varaldo… - British Journal of …, 2007 - europepmc.org
We report the final results of a prospective multi-centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …
[引用][C] Adding low dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with …
M CLAVIO - Br J Haematol., 2007 - cir.nii.ac.jp
Adding low dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may
improve disease-free and overall survival in elderly patients with non-M3 acute myeloid …
improve disease-free and overall survival in elderly patients with non-M3 acute myeloid …